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Effect of Exposure Route, Regimen, and
Duration on Benzene-Induced Genotoxic
and Cytotoxic Bone Marrow Damage in Mice
by Raymond R. Tice,* Carol A. Luke,t and Robert T. Drewt
Mice were exposed to benzene for 13 to 14 weeks by inhalation for either 3 or 5 consecutive days per week
or by gavage for 5 consecutive days per week. A weekly evaluation of peripheral blood smears for
micronucleated (MN) erythrocyte frequencies and for the percentage ofpolychromatic erythrocytes (PCE)
indicated that the induction ofMN-PCE by benzene depended on the sex and strain ofmice and on the route
ofexposure, but not on the inhalation regimen oron theexposure duration. The frequency ofMNnormochro-
matic erythrocytes (NCE) not only depended on the sex and strain ofmice and on the route ofexposure, but
directly depended on the inhalation regimen and on the exposure duration. Similarly, the extent of
erythropoietic depression in benzene-exposed mice was dependent on sex, mouse strain, exposure duration,
and route. However, in contrast to the MN-NCE data, the 3 day/week exposure regimen induced a more per-
sistent depression in erythropoiesis than the 5 day/week exposure regimen. Exposure to benzene also induced
in mice a significant depression in packed cell volume (PCV) and bone marrow cellularity, the magnitude
of which depended on the sex and strain of mice and on the regimen and route of exposure.
Introduction
Benzene is used extensively in industry and commerce
and presents many risks inregard to environmental con-
tamination and human health (1,2). Exposure to benzene
in man and animals results in avariety ofadverse health
effects, including an increased risk for cancer and aplas-
tic anemia(2-8). In animal studies, benzene hasbeen dem-
onstrated to induce genotoxic and cytotoxic damage in
bone marrow and, under acute exposure conditions, the
magnitude of the damage depends on the dose, sex,
strain, and species of the animal (2,9,10). However, few
studies have evaluated the effect of exposure duration,
regimen, or route on the levels ofgenotoxic damage in-
duced by benzene under extended exposure conditions.
Barale et al. (11) evaluated micronuclei (MN)frequencies
in peripheral blood erythrocytes ofCD-1 mice exposed to
benzene over an 8-weekperiod, whereas Choy et al. (12)
evaluated MN frequencies in peripheral bood erythro-
cytes of B6C3Fj mice treated with benzene for up to 2
years (6). In both studies, benzene was administered by
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gavage on 5 consecutive days per week, and MN analy-
sis was limited to normochromatic erythrocytes (NCE).
The conclusion inboth studieswasthatthe abilityofben-
zene to induce bone marrow genotoxic damage declined
with increasing exposure duration. However, since the
frequency of micronucleated NCE depends on several
factors, other interpretations of the data are possible.
To specifically evaluate the effect ofexposure duration
on the ability ofbenzene to induce genotoxic damage in
murine bone marrow, MN frequencies in both NCE and
polychromatic erythrocytes (PCE) were evaluated in
peripheral blood (13-15). This approach, first introduced
by MacGregor and his colleagues (16,17), permits in the
same animal an evaluation ofboth recently induced and
chronically accumulatedbone marrow damage. Because
ofthe lack ofinformation on benzene-induced genotoxic
damage under multiple exposure conditions, the study
was also designed to evaluate sex and strain differences
in response and to compare the magnitude ofthe damage
induced by inhaled benzene with benzene given by oral
gavage. In addition, because Irons (18) reported that in-
termittent treatments of mice with metabolites of ben-
zene (hydroquinone and phenol) induced more bone mar-
row damage (i.e., loss in cellularity) than chronic
treatments at the same doses, two exposure regimens
were used in the inhalation study. An evaluation in the
peripheral blood ofthe percentage of PCE among total
erythrocytes was included to provide an assessment of
the rate of erythropoiesis and thus a measure of boneTICE, LUKE, AND DREW
marrow cytotoxicity (19). At the completion of the ex-
posure period, two additional measures on bone marrow
toxicity-a depression in packed cell volume and in bone
marrow cellularity-were assessed.
Materials and Methods
Chemicals and Animals
Benzene (CAS No. 71-43-2), reagent grade, thiophene
free, was obtained from Mallinckrodt Chemical Co.
(Paris, KY). Acridine orange and reagent grade corn oil
was obtained from Sigma Chemical Co. (St. Louis, MO).
Male DBA/2 and C57BL/6 mice were obtained from
Jackson Laboratories (Bar Harbor, ME) at 9 weeks of
age; maleB6C3Fj (C57BL/6 x C3H)micewere obtained
from Frederick Cancer Research Center(Frederick, MD)
asweanlings. Afterreceipt, the mice were acclimatedfor
aperiod of2 weeks in standard laboratory stainless-steel
cages with corn cob bedding(Bed O' Cobs, J. R. Nielson
and Sons, Inc.). The population density was kept at no
greater than one animalper90 cm2, undercontrolled lab-
oratory conditions [i.e., 22 + 20C, 50 + 15% relative hu-
midity, 20 air exchanges per hr and a 12-hrphotoperiod
(light: 0700-1900)]. Food (Purina Lab Rodent Chow 5001)
and water were provided ad libitum. Coded toe clipping
enabled identification of individual animals throughout
the experiment.
Exposure Protocol
Groups ofmice (n = 6-10)were a)exposed to either300
ppm benzene orto ambient air(6 hrper day)foraperiod
of 13 weeks, using one oftwo exposure regiments (regi-
men 1:5 consecutive exposure daysperweek; regimen 2:3
consecutive exposure daysperweek)(14,15); orb)given
benzene orally (400 mg/kg diluted in corn oil, which was
administered at a volume of 80 mL/kg) by gavage on 5
consecutive days perweek for 14 weeks (16). Benzene at
300 ppm was used because ofthe ability of this concen-
tration to induce adverse health effects(e.g., leukopenia,
anemia, cancer)(5,20-22) andgenotoxic damage(23,24) in
exposedmice andbecause this concentration was not ex-
pected to induce overt mortality over the course of the
study (5). Furthermore, 300 ppm benzene was believed
to be within the linear portion ofthe dose range for the
absorption ofinhaled benzene in mice (25). Benzene at a
dose of400mg/kgwas usedin the gavage studybecause
this dose was estimated to exceed the total amount of
benzene absorbed by a mouse during a 6-hr exposure to
300 ppm, because it induced close to the maximal MN-
NCE response in B6C3F1 mice in the National Toxicol-
ogy Program (NTP)benzene cancerbioassay study(12),
and because it was similar to the maximum dose usedby
Barale et al(11). The selection ofthe inhalationregimens
wasbased on studiesby Irons(18), inwhichgreater cyto-
toxicdamage occurred whenmice were treated with var-
ious metabolites ofbenzene on 3 days per week as com-
pared to 6 days per week.
DBA/2 and C57BL/6 mice were included in this study
because these two strains are well known for their
differential organ-specific carcinogenicity and toxicity fol-
lowing repeated exposures to polycyclic aromatic
hydrocarbons (26) and because they differ in their sensi-
tivity tobenzeneasjudgedbytheinductionofsisterchro-
matid exchanges (SCE) (23), the inhibition of red blood
cell formation (27), and the induction ofmicronucleated
PCE in bone marrow (28). Also, following repeated but
not acute exposures to benzene, DBA/2 mice exhibit a
greater amount ofwater-soluble metabolites ofbenzene
and covalent-binding in bone marrow than similarly ex-
posed C57BL/6 mice (27).
B6C3F1 were included to further evaluate and compare
the sensitivity ofthe strainusedin the NTPbenzene can-
cer bioassay (6) against the other two strains. Female
mice ofone strainwere included in the study because the
genotoxic and carcinogenic activity ofbenzene has been
shown to be highly sex dependent (10). The time-
weighted average concentration ofbenzene for regimen
1 andregimen2 in the inhalation studywas299.8ppm(63
exposure days)and300.4ppm(39 exposure days), respec-
tively. Additional details ontheinhalationexposure study
and on the gavage study can be found in Luke et al.
(13,14) and Tice et al. (15), respectively.
Hematologic and Cellular Analyses
Peripheral blood smears were prepared weekly as
described in Luke et al. (13)from all micebeginning with
the weekpriorto the firstweekofexposure. Slides were
fixed in absolute methanol and stained for analysis with
acridine orange and scored as described in Luke et al.
(13). In each animal at each sample time, 1000 PCE and
1000 NCE were scored for the frequency of
micronucleated cells, and 1000 erythrocytes were evalu-
ated for the percentage of PCE.
At the completion of the study, a single tibia was ob-
tained from each mouse, cleaned ofadheringtissue, and
the marrow removed by repeatedly flushing the bone
cavity withphosphate-buffered saline(PBS)(pH 7.4; r\.,10
mL). The marrow waspelleted,resuspendedinPBS, and
the total number of nucleated cells determined using a
Coulter electronic counter (Model ZBI).
At the completion ofthe study, the packed cell volume
(PCV) was measuredusingheparinizedmicro-hematocrit
tubes (Clay-Adams, Inc., NY). The tubes were cen-
trifuged (15,500 rpm) for 5min in ahematocrit centrifuge
(Drummond) and read in a hematocrit reader (Drum-
mond).
Statistical Analysis
The alpha level was set at0.05. Complete details ofthe
statistical analyses ofthe MN andpercent PCE data can
be found in Luke et al. (13,14). Briefly, temporal averages
for MN-PCE, MN-NCE, and the percentage of PCE
were calculated for each animal by summing the values
across time (except for the MN-NCE data, week 0 was
omitted fromthe exposed mouse calculations) and divid-
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ingby the number ofsamples evaluated. Usingtemporal
averages, the data were evaluated for benzene, sex,
strain, regimen, and route of exposure effects using a
two-way Brown Forsythe analysis ofvariance(ANOVA)
based on separate group variances (29). Group mean data
were compared using Student's t-test based on separate
variances after the alpha level had been Bonferroni cor-
rected for the appropriate number of multiple compari-
son. Two-way ANOVA and Student's t-tests were also
usedto evaluate PCV and cellularity data. In caseswhere
a signifcant strain and/or sex difference in control data
was observed, the difference between control and ex-
posed data were used inthe statistical analysis. Student's
t-tests were used to determine at which sample times the
percentage of peripheral blood PCE in the benzene-
exposed mice were significantly different from control
values. To evaluate for an exposure duration-dependent
alteration in the induction of genotoxic damage in the
bone marrow ofbenzene-exposed mice, weeklyfrequen-
cies ofMN-PCE in each animal were analyzed by multi-
ple regression analysis. As with the calculation of tem-
poral averages, pre-exposure MN-PCE data were
omitted from the analysis of benzene-exposed mouse
data.
Results
Complete data at every sample time for MN-PCE, MN-
NCE and the percentage ofPCE in peripheral blood of
each mouse in the inhalation study can be found in Luke
et al. (13,14) and for the gavage study in Tice et al. (15)
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MN-NCE Levels
There was an exposure duration-dependent increase in
thefrequencyofMN-NCE inmice exposedto benzeneby
inhalation (Fig. 1) orgivenbenzenebygavage (Fig. 2). In
the inhalation study, mice exposed tobenzene 5 daysper
week exhibited a significantly greater increase (p <
0.0001) in the frequency ofMN-NCE than mice exposed
3 daysperweek(Table 1). Within eachregimen ofthe in-
halation study, the increase in MN-NCE depended onthe
sex (male > female; p < 0.0001) and on the strain
(C57BL/6 - B6C3Fj > DBA/2; p < 0.0001) ofmice. The
frequency of MN-NCE in male B6C3F1 mice ad-
ministered benzene by gavage 5 days perweek was sig-
nificantly less (p < 0.0001) than that in male mice ofthe
same strain exposed to benzene 5 days per week by in-
halation. In male andfemalemice inhalingbenzene 3 days
perweek, the MN-NCE levels appeared to reach steady-
state conditions by about6weeks ofexposure (Fig. 1). In
female DBA/2 mice inhaling benzene 5 days per week
(Fig. 1) and in male B6C3Fj given benzene by gavage
(Fig. 2), similarkinetics intherise andsaturationofMN-
NCE levels were observed. However, steady-state con-
ditions were not attained over the duration ofthe study
in male mice exposed to gaseous benzene on 5 days per-
week. Strain differences in the kinetics ofMC-NCE ac-
cumulation in these mice are readily apparent (Fig. 1). In
male DBA/2 mice, the frequency ofMN-NCE increased
over the duration of the study while, in the other two
strains of mice, MN-NCE frequencies peaked around
week 6 ofthe inhalation exposure. Thispeakinfrequency
was followedbya¶decline overthe following4 to 5weeks
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FIGURE 1. Frequency ofperipheral blood MN-NCE across time in male DBAI2 mice, female DBA/2 mice, male B6C3Fj mice, and male C57BL/6
mice exposed to 300 ppm benzene. (A) Data on benzene-exposed mice. The dashed line indicates the upper 95% confidence limit for MN-NCE
frequency in control mice. (B) Data on control mice. (0-0) Mice exposed 3 days per week; (0-0) mice exposed 5 days per week. Error bars
indicate 95% confidence limits.
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FIGURE 2. Frequency of peripheral blood MN-NCE and MN-PCE
across time in male B6W3F1 mice administered 400 mg/kg benzene
by gavage. (A) Data on benzene-exposed mice. (B) Data on control
mice. The dashed line indicates the upper 95% confidence limit for
MN-NCE/MN-PCE frequency in control mice. (0-0) MN-NCE;
(@-@) MN-PCE. Error bars indicate 95% confidence limits.
and then by a second increase in MN-NCE levels at the
end of the study.
MN-PCE Levels
Exposure to benzene by inhalation or by gavage in-
duced ahighly significant increase (p < 0.0001) in the fre-
quency of MN-PCE detected in the peripheral blood of
mice (Figs. 2 and 3; Table 2). Within each strain used in
the inhalation study, the increase in thefrequency ofMN-
PCE was independent ofregimen (p values between 0.07
and 0.54). After pooling MN-PCE data, where accepta-
ble, between exposure regimens and correcting for strain
differences in controlfrequencies, the ability ofbenzene
to induce MN depended(p < 0.0001) on the sex(male >
female DBA/2 mice) and the strain DBA/2 > C57BL/6 -
B6C3F1) ofmice and on the route of exposure (inhalation
> oral). Except for B6C3F1 mice exposed to 300 ppm
benzene for 3 days per week, regression analyses ofin-
dividual mouse MN-PCE frequencies against exposure
duration revealed only an occasional animal with a signif-
icanttime-dependent alteration. AmongthemaleB6C3Fj
mice exposed to benzene 3 days per week, MN-PCE
levels in three or the six mice had a significant positive
slope when regressed against exposure duration. While
not significant, the remainingthree mice also had aposi-
tive exposure duration-dependent slopeforMN-PCE re-
sponse.
PCE Frequency
Exposure to benzene by eitherroute orinhalation regi-
men initially induced a significant depression in the per-
centage ofPCE intheperipheralbloodofmice ofallthree
strains (Figs. 4 and 5). The extent and duration of the
depression depended on the sex, strain, and exposure
regimen. Female DBA/2 mice exhibited the least initial
suppression of erythropoiesis and the percentage of
peripheral blood PCE returned to control levels by the
third week of exposure. A two-way ANOVA of the fe-
male miceterporal averagesprsented inTable 3indicated
that while benzene significantly depressed the percent-
age ofPCE (p = 0.0201), the extent ofdepression was not
dependent on exposure regimen (p = 0.1523). Although
male mice ofall three strains experienced a marked sup-
pression of PCE production after the completion ofthe
first orsecondweekofinhalation exposure, theeffect was
more pronoucned in DBA/2 mice and more pronounced
in mice exposed to benzene 3 days per week (Fig. 4). A
two-way ANOVA of temporal averages (Table 3) re-
vealed a significant difference between inhalation ex-
posure regimens in C57BL/6 and male DBA/2 mice (p <
0.05) and, aftercorrectingforstrain differences in control
data, a significant difference among strains (p < 0.0001)
in the ability of benzene to suppress erythropoiesis in
both regimens. Treatment with 400 mg/kg benzene by
gavage initially resulted in a significant depression of
Table 1. Peripheral blood MN-NCE temporal averages in benzene-exposed mice.
Exposure Controlb Exposedb
Strain Sex Routea regimen Mean SEM n Mean SEM n
B6C3F, M Gav 5 day 2.20 + 0.129 9 15.32 + 2.341 9
B6C3F, M Inh 5 day 1.70 ± 0.186 6 30.73 ± 0.906 6
B6C3F, M Inh 3 day 1.97 + 0.204 6 12.32 + 0.522* 6
C57B1/6 M Inh 5 day 2.93 ± 0.174 6 34.73 + 1.290 6
C57B1/6 M Inh 3 day 3.28 ± 0.295 6 15.78 + 0.593 5
DBA/2 M Inh 5 day 1.70 + 0.157 6 23.47 + 1.040 6
DBA/2 M Inh 3 day 1.35 + 0.034 6 10.55 ± 0.633 6
DBA/2 F Inh 5 day 1.35 ± 0.102 6 7.72 ± 0.995 6
DBA/2 F Inh 3 day 1.15 + 0.177 6 4.98 ± 0.497 6
aAbbreviations: gav, gavage; inh, inhalation.
bMean number of MN-NCE per 1000 NCE + SEM among n mice. *Significantly different from corresponding control values at a = 0.05.
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PCE levels in the peripheral blood ofmale B6C3F1 mice
which persisted for only 2 weeks (Fig. 5). The lack of a
significant depression in the percentage of PCE in
gavage-treated mice, as determined by an analysis of
temporal averages (Table 3), is due to the lack ofpersis-
tence in the depression oferythropoiesis in these animals.
Packed Cell Volume
Exposure to benzene induced a significant depression
(p < 0.01)in PCV in mice evaluated at the completion of
the study (Table4). In B6C3Fj and C57BL/6mice, the ex-
tent ofdepression was independent ofthe inhalation regi-
men. Exposure to benzene by inhalation induced a
greater depression in male B6C3Fj mice than benzene
given by gavage. After correcting for differences in PCV
levels in control animals, the extent ofdepression in mice
exposed to gaseousbenzene on3 days perweekdepended
on the strain(B6C3Fi - C57BL/6 > DBA/2; p = 0.0163),
while in DBA/2 mice, the extent ofdepression was sex-
dependent (male > female; p < 0.025).
Table 2. Peripheral blood MN-PCE temporal averages in benzene-exposed mice.
Exposure Controlb Exposedb
Strain Sex Routea regimen Mean SEM n Mean SEM n
B6C3F, M Gav 5 day 2.23 + 0.200 9 24.04 + 1.054* 9
B6C3F, M Inh 5 day 2.42 + 0.340 6 94.88 + 3.211* 6
B6C3F, M Inh 3 day 2.97 ± 0.229 6 99.90 + 3.838* 6
C57B1/6 M Inh 5 day 5.13 + 0.233 6 104.32 ± 3.546* 6
C57B1/6 M Inh 3 day 4.45 + 0.281 6 100.26 + 2.905* 5
DBA/2 M Inh 5 day 2.05 + 0.131 6 107.85 + 5.529* 6
DBA/2 M Inh 3 day 1.53 + 0.150 6 121.23 ± 1.700* 6
DBA/2 F Inh 5 day 1.55 + 0.211 6 20.93 ± 3.173* 6
DBA/2 F Inh 3 day 1.90 ± 0.188 6 24.40 + 4,454* 6
aAbbreviations: gav, gavage; inh, inhalation.
bMean number of MN-PCE per 1000 PCE ± SEM among n mice.
'Significantly different from corresponding control values at a = 0.05.
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FIGURE 4. Group mean frequency ofperipheral blood PCE across time in female DBA/2 mice, male DBA/2 mice, male B6U3F mice, and male
C57BL/6 mice exposed to 300 ppm benzene, presented as the percentage ofthe corresponding control group data. (E-EI) Mice exposed 3 days
per week; (0-0) mice exposed 5 days per week. Solid symbols indicate statistically significant differences between control and benzene-exposed
mice as determined by Student's t-test at a = 0.05.
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FIGURE 5. Group mean frequency ofperipheral blood PCE across time
in male B6C3F1 mice administered 400 mg/kg benzene, presented
as the percentage ofthe corresponding control group data. Solid sym-
bols indicate statistically significant differences between control and
benzene-exposed mice as determined by Student's t-test at a = 0.05.
Bone Marrow Cellularity
Based on an analysis ofcellularity in the tibia bone mar-
row ofmice at the completion ofthe study period(Table
5), exposure to benzene significantly depressed the num-
ber of bone marrow cells in male (p < 0.0001) but only
marginally so in female (p = 0.0644) mice. Among male
mice, the extent ofthe depression depended on the route
ofexposure (inhalation > oral; p = 0.0120), but not on the
inhalation exposure regimen(p > 0.05). Within the inha-
lation study, the depression in cellularity depended on the
sex (male > female; p = 0.0002) and strain (DBA/2 <
B6C3F, - C57BL/6; p = 0.0012) of mice.
Discussion
The mouse peripheral blood MN assay is unique in that
Table 3. Peripheral blood percentage PCE temporal averages in benzene-exposed mice.
Exposure Controlb Exposedb
Strain Sex Routea regimen Mean SEM n Mean SEM n
B6C3FI M Gav 5 day 3.72 + 0.159 9 3.53 + 0.121 9
B6C3F, M Inh 5 day 5.75 + 0.598 6 2.76 + 0.232 6
B6C3F, M Inh 3 day 7.58 + 1.429 6 2.36 + 0.515 6
C57B1/6 M Inh 5 day 5.13 + 0.275 6 3.91 + 0.455* 6
C57B1/6 M Inh 3 day 5.41 + 0.537 6 3.09 + 0.533* 5
DBA/2 M Inh 5 day 3.49 + 0.152 6 1.48 + 0.264* 6
DBA/2 M Inh 3 day 3.56 + 0.236 6 0.48 + 0.072* 6
DBA/2 F Inh 5 day 3.51 + 0.129 6 2.40 + 0.315 6
DBA/2 F Inh 3 day 3.83 + 0.178 6 3.09 + 0.520 6
aAbbreviations: gav, gavage; inh, inhalation.
bMean percentage of PCE (based on analyzing 1000 erythrocytes) ± SEM among n animals. *Significantly different from corresponding control values at a = 0.05.
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Table 4. Mean packed cell volume in benzene-exposed mice at the completion of the 13- to 14-week exposure period.
Exposure Controlb Exposedb
Strain Sex Routea regimen Mean SEM n Mean SEM n % Depression
B6C3F, M Gav 5 day 48.3 + 1.24 9 39.6 + 0.90 9 18.0*
B6C3F, M Inh 5 day 44.9 + 2.94 4 30.7 + 2.33 6 31.6
B6C3F, M Inh 3 day 38.9 + 2.04 6 34.2 + 0.77 5 12.1
C57B1/6 M Inh 5 day 45.8 + 2.19 6 36.5 + 1.36 6 20.3
C57B1/6 M Inh 3 day 44.0 + 1.18 6 21.9 + 2.94 5 50.2
DBA/2 M Inh 5 day 48.0 + 0.66 6 34.1 + 3.00 4 29.0*
DBA/2 M Inh 3 day 44.8 + 0.96 6 29.8 + 1.76 6 33.3
DBA/2 F Inh 5 day 47.8 + 0.40 6 40.6 + 1.52 6 15.2
DBA/2 F Inh 3 day 43.6 + 1.01 6 37.8 + 2.03 4 13.3
aAbbreviations: gav, gavage; inh, inhalation. PCV = packed cell volume
bMean PCV (%) ± SEM among n animals.
*Significantly different at a = 0.05.
Table 5. Mean tibia cellularity in benzene-exposed mice at the completion of the 13- to 14-week exposure period.
Exposure Controlb Exposedb
Strain Sex Routea regimen Mean SEM n Mean SEM n % Depression
B6C3F, M Gav 5 day 7.29 + 0.564 9 3.52 + 0.405 9 51.7*
B6C3F, M Inh 5 day 11.35 + 1.207 5 4.41 + 0.769 6 61.1*
B6C3F, M Inh 3 day 14.97 + 0.981 6 4.27 + 0.183 5 71.5
C57B1/6 M Inh 5 day 14.91 + 1.492 6 6.02 + 0.417 6 59.6
C57B1/6 M Inh 3 day 14.68 + 1.122 6 5.47 + 0.346 5 62.7
DBA/2 M Inh 5 day 5.49 + 0.540 6 0.85 + 0.110 5 84.5
DBA/2 M Inh 3 day 6.71 + 0.437 6 0.97 + 0.122 6 85.5
DBA/2 F Inh 5 day 2.75 + 0.377 6 1.94±+ 0.432 6 29.5
DBA/2 F Inh 3 day 5.50 + 0.935 5 2.31 + 0.718 4 58.0
aAbbreviations: gav, gavage; inh, inhalation.
bMean number of nucleated cells per tibia (x 106) ± SEM among n animals.
*Significantly different at a = 0.05.
it enables, under multiple exposure conditions, a concur-
rent evaluation within the same animal ofboth acutely in-
duced (i.e., within the last 1 to 2 days) and chrol,ically ac-
cumulated (i.e., over 35 days) bone marrow damage
(16,17,30). Thus, this assay is ideally suited for evaluat-
ing exposure duration-dependent alterations in bone mar-
row sensitivity to genotoxic agents. However, an in-
terpretation of exposure duration-dependent alterations
in bone marrow damage based on an analysis ofMN-NCE
only can be misleading because the frequency of
micronucleated NCE is dependent not only on the fre-
quency with which MN-PCE are induced but also on the
rate of erythropoiesis, the transit time between enucle-
ation of the erythrocyte precursor in the bone marrow
and the identification of the cell as an NCE, and on the
lifespan of both the normal and the micronucleated NCE
under the study conditions (31).
Choy et al. (12) observed diminished levels of MN-NCE
with increasing exposure duration in the peripheral blood
of B6C3F 1 mice given benzene by gavage for 17 days, 54
days, and 103 weeks. In male CD-1 mice treated by
gavage with benzene over an 8-week period, Barale et al.
(11) observed a peak in MN-NCE frequency at about 5
weeks of exposure, followed by a decline in frequency
over the remaining 3 weeks. Barale and his colleagues in-
terpreted this lack ofsteady-state conditions to suggest
either the selection of cells resistant to benzene, an in-
creased detoxificaton ofbenzene, and/or a decreased abil-
ity of the animals to metabolize benzene. This interpre-
tation is not unreasonable considering that metabolic
stt -'S on benzene havi. demuonstrated an increased rat,
of benzene clearance/metabolism in rodents under
repeated exposure conditions (22,32-36).
Theoretically, with multiple exposures, MN-NCE fre-
quencies should attain steady-state conditions after the
duration ofthe exposure period has exceeded the aver-
age NCE lifetime (i.e., some 5 to 7 weeks after the first
exposure to benzene). In the present study, apparent
steady-state conditionsforMN-NCE levels were attained
after about 5 weeks in female DBA/2 mice exposed to
benzene by both regimens, in male mice of all three
strains exposed to benzene for 3 days per week, and in
male B6C3F, mice administered benzene by gavage on
5 days per week. However, in male mice exposed to ben-
zene by inhalation for 5 days perweek, the frequency of
MN-NCE never attained steady-state conditions (Fig. 1).
Differences among the three strains in the kinetics of
MN-NCE accummulation are readily apparent. In male
DBA/2mice, the frequency ofMN-NCE continued to in-
crease throughout the study, suggestingincreased geno-
toxic sensitivity with increasing exposure duration. In
male B6C3Fi and C57BL/6 mice, the frequency ofMN-
NCE peaked around week 6, declined over the next 4
weeks, and then increased again near the end ofthe 13
week exposure period. The pattern ofthe MN-NCE re-
sponse inthemale mice oftheselattertwo strainsisquite
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similar to that observedby Barale et al(11)formale CD-1
mice given benzene by gavage. The notable difference is
that the duration ofthe studypresentedhere waslonger,
permitting the detection ofa second increase in the fre-
quency ofMN-NCE. The lack ofsteady-state conditions
for MN-NCE frequencies suggests a duration-dependent
alteration in the ability of benzene to induce genotoxic
bone marrow damage in mice.
By evaluatingthe frequncy ofMN-PCE throughout the
course ofthe exposure period, this question ofwhether
the ability ofbenzene to induce genotoxic damage(as de-
fined by MN formation) in bone marrow is modulated by
exposure duration can be examined critically. The lack of
a time-dependent change in MN-PCE levels in the
peripheral blood ofbenzene-exposed mice overthe 13- to
14-week exposure period, regardless ofthe route of ex-
posure or the exposure regimen, indicates that modula-
tion ofsensitivity and/or ofmetabolism did not alter the
ability ofbenzene or its metabolites to induce bone mar-
row genotoxic damage. However, the age range over
which this evaluation was conducted(i.e., 2-6 months) is
relatively short, and, in more extensive studies (2-12
months ofage), the age ofthe animal has been found to
have aprofound effect on thelevel ofgenotoxic and cyto-
toxic damage (asmeasuredbythe inductionofsisterchro-
matid exchanges and the inhibition ofcellular prolifera-
tion kinetics) induced by a single exposure to benzene
(23). Thus, more extensive studies may reveal an age-
dependent modulation in benzene-induced bone marrow
damage.
While the induction ofMN-PCE was independent ofex-
posure regimen, the exposure duration-dependent ac-
cumulation ofMN-NCE was greater in mice exposed to
benzene for 5 days per week than in mice exposed for 3
days per week. The difference in MN-NCE levels be-
tween regiments within a single sex/strain can be read-
ily explained by the differences in the number of ex-
posure days per week involved and by the generally
greater suppression oferythropoiesis in mice exposed to
benzene 3 days perweek. That exposure tobenzene sup-
presses the rate of erythropoiesis is not surprising in
view of the large number of studies demonstrating the
toxic effects of benzene on the hematopoietic system
(2,8,10,12). The greater persistence ofPCE suppression
in male mice exposed to benzene for only three days per
week was particularly striking. These data support the
benzene metabolite studies ofIrons (18) and provide evi-
dence that the extent ofbenzene-induced toxicity is not
simply related to the number ofexposure daysperweek.
The results ofthe analyses ofPCV andbone marrow cel-
lularity data collected at the completion ofthe exposure
period reveal, with the single exception ofbone marrow
cellularity data for female DBA/2 mice, a significant
depression in both end points among all groups ofmice.
However, while the cellularity data are always slightly
more depressed in the mice exposed to benzene 3 days
per week, the difference is not significant within mice of
any sex or strain. The PCV dlata indicate a regimen-
dependent difference in the magnitude ofthe depression
induced by exposure to gaseous benzene, but only in
DBA/2 mice. Itis note clearwhythese various measures
ofbone marrow toxicity are not all in agreement. How-
ever, it mustbe remembered that the PCV and cellular-
ity datawere obtained at the completion ofthe exposure
period and at a time when the percentage ofPCE in the
peripheral bloodofbenzene-exposed mice wasnot signifi-
cantly different from control values.
Male DBA/2 mice exposed to benzene routinely dem-
onstrated more genotoxic (MN induction) and cytotoxic
(% PCE, PCV, cellularity) damage than did female
DBA/2 mice. The increasedlevel ofdamage in male mice
isnotunexpected, asthere arenumerousreportsindicat-
ingthatmale mice aremore sensitive tobenzenethan are
female mice (10). The frequency of micronucleated
erythrocytes in the peripheral blood ofbenzene-exposed
micealso depended on the strainofmice. However,while
male DBA/2 mice exhibited the highestfrequencyofMN-
PCE, this strain exhibited the lowest frequency ofMN-
NCE. Consideringthe results ofprevious studies(22,27),
the presence ofagreaterfrequencyofMN-PCE in male
DBA/2 mice when comparedtomale C57BL/6 mice isnot
surprising. However, the factthatthe differences inthe
MN-PCE temporal averages amongthe two strains was
only approximately 10% is noteworthy. Harper and Le-
gator (28), in a bone marrow MN study, reported that a
single dose ofbenzene administered by gavage induced
about a 1.5-fold greater increase in MN-PCE in male
DBA/2 mice than inmale C57BL/6 mice, a difference that
increased following a course ofmultiple treatments. The
different route of exposure used in these two studies
probably accountsforthelackofagreement in these data.
The strain-dependent difference in MN-NCE levels can-
not be accounted forby the differences in MN-PCE fre-
quencies amongstrains. Rather, the differencesinthe ki-
netics ofMN-NCE accumulation observed for the three
strains must resultfrom the strain-specific effects ofben-
zene on the rate of erythropoiesis. The strain with the
greatest suppression also exhibited the slowest increase
in MN-NCE levels. Males ofallthree strains exposed to
gaseous benzene 5 days per week exhibited a similar
depression in PCV values. Among mice exposed 3 days
per week, DBA/2 males exhibited the greatest absolute
decrease in PCV. However, this same strain exhibited
the least absolute decrease in bone marrow cellularity
among animals exposed for either 3 or 5 days per week.
Benzene, when administered by inhalation (300ppm; 5
days per week, 6 hr per day), induced in male B6C3F1
mice a much greater level ofgenotoxic (MN levels) and
cytotoxic (% PCE, PCV, and bone marrow cellularity)
damage than when given by gavage (400 mg/kg; 5 days
perweek). In this and inpreviousgavage studies(11,12),
the frequency of MN-NCE in the peripheral blood of
males treated with 500 mg/kg ofbenzene administered
5 days per weekfor some 8 to 17 weeks oftreatment at-
tained a level of 10 to 20 micronucleated cells per 1000
NCE. In contrast, the MN-NCE levels in B6C3F1 mice
exposed 5 days per week for 13 weeks to 300 ppm ben-
zene attained alevel ofsome 50 to 60MN-NCE per 1000
NCE. The difference in the frequency of MN-PCE in
mice exposed to benzene by the two different routes is
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even more profound. Similarly, the depression in PCV
and in bone marrow cellularity was much more severe in
mice exposed to benzene byinhalation than inmice given
benzene by gavage. This considerable difference in the
level ofgenotoxic damage induced in thebone marrow of
benzene-exposed mice depending on the route of ex-
posure agrees with the pharmacokinetic studies ofHen-
derson and co-workers (37,38). These investigators
reported that much higherlevels ofthe various metabo-
lites ofbenzene canbe achieved inthebone marrowwhen
mice are exposed to benzene via the lungs than when it
is administered by gavage.
The complex response ofthe mouse hematopoietic sys-
tem to benzene depends on the sex and strain of the
mouse, the route of exposure and, for some end points,
on the duration and regimen oftreatment. The results of
these studies indicate that an evaluation of exposure
duration-dependent changes in bone marrow sensitivity
based simply on an evaluation of peripheral blood MN-
NCE frequencies are inadequate. The observation that
the depression in the rate oferythropoiesis (as measured
by the percentage ofPCE in peripheral blood) depended
on the inhalation regimen needs to be confirmed and ex-
panded. Such data clearly have implications for the ex-
trapolation ofanimal data to human exposure situations.
It is not obvious why suppression oferythropoiesis per-
sisted for a longer duration in male mice exposed to 300
ppm benzene for fewer days per week. However, since
proliferating cells appear to be more susceptible to the
cytotoxic actions ofbenzene than are the normally quies-
cent stem cells and since benzene appears to inhibit stem
cell proliferation, the 3-day exposure regimen probably
provides agreater opportunity fortoxicity (8,18). The sig-
nificant dependence of the level of genotoxic and cyto-
toxic damage on the route ofexposure suggests that the
extrapolation ofanimal data from gavage studies to hu-
man occupational exposure situations may also be inade-
quate. The concentration of benzene (300 ppm) used in
this study greatly exceed the current and recent occupa-
tional exposure limits. Furthermore, although 300 ppm
benzene was believed to be within the linear portion of
the dose range for the absorption ofinhaled benzene in
mice (24), more recent data(37,38) suggest that this dose
lies above the linear portion ofthe dose-response curve
forinhaled benzene metabolism. Thus, there is aneedfor
additional studies on regimen- and route of exposure-
dependent responses at lower concentrations ofbenzene.
The authors gratefully acknowledge the assistance ofR. Boucher, A.
Giovanelli, C. Brooks, W. Maston, V. Miller, and D. Paquette in these
studies. This research was supported at Brookhaven National Labora-
tory by the National Institute of Environmental Health Sciences un-
der Interagency Agreement Y01-CP-10207 and by the Department of
Energy underprime contract DE-AC02-76CH00016. Accordingly, the
U.S. Government retains a nonexclusive, royalty-free license to pub-
lish orreproduce thepublished form ofthiscontribution, orallow others
to do so, for U.S. Government purposes.
REFERENCES
1. Sittig, M. Benzene. In: Hazardous and Toxic Effects ofIndustrial
Chemicals. Noyes Data Corp., Park Ridge, NJ, 1979, pp. 52-59.
2. IARC. Evaluation ofthe Carcinogenic Risk ofChemicals to Hu-
mans, Vol. 29. International Agency for Research in Cancer, Lyon,
France, 1982, pp. 93-148.
3. Maltoni, C., and Scarnato, C. First experimental demonstration
of the carcinogenic effects of benzene: Long-term bioassays on
Sprague-Dawley ratsbyoraladministration. Med. Lav. 70: 353-357
(1979).
4. Snyder, C. A., Goldstein, B. D., Sellakumar, A. R., Bromberg, I.,
Laskin, S., andAlbert, R. E. The inhalation toxicology ofbenzene:
Incidence ofhematopoietic neoplasms and hematoxicity in AKR/J
and C57B1/6J mice. Toxicol. Appl. Pharmacol. 54: 323-331 (1980).
5. Cronkite, E. P., Bullis, J. E., Inoue, T., and Drew, R. T. Benzene
inhalation produces leukemia in mice. Toxicol. Appl. Pharamcol.
75: 358-361 (1984).
6. NTP Technical Report 289. NTP Technical Report on the Toxi-
cology and Carcinogenesis Studies ofBenzene in F244/N Rats and
B6C3F1 Mice(Gavage Studies). NIH Publication No. 84-2545, U.S.
Department of Health and Human Services, Washington, DC,
1985.
7. Aksoy, M. Benzene as aleukemogenic and carcinogenic agent. Am.
J. Ind. Med. 8: 9-20 (1985).
8. Snyder, C. A. Benzene. In: Ethyl Browning's Toxicity and Metab-
olism of Industrial Solvents (R. Snyder, Ed.), Elsevier, Amster-
dam, 1987, pp. 3-37.
9. Dean, B. J. Genetic toxicology of benzene, toluene, xylenes and
phenols. Mutat. Res. 47: 75-97 (1977).
10. Dean, B. J. Recent findings on the genetic toxicology ofbenzene,
toluene, xylenes and phenols. Mutat. Res. 154: 153-181 (1985).
11. Barale, R., Giorgelli, F., Migliore, L., Ciranni, R., Casini, D., Zuc-
coni, D., and Loprieno, N. Benzene induces micronuclei in circulat-
ing erythrocytes of chronically treated mice. Mutat. Res. 144:
193-196 (1985).
12. Choy, W. N., MacGregor, J. T., Shelby, M. D., andMaronpot, R. R.
Induction ofmicronuclei by benzene in B6C3F, mice: Retrospec-
tive analysis ofperipheral blood smears from the NTPcarcinogen-
esis bioassay. Mutat. Res. 143: 55-59 (1985).
13. Luke, C. A., Tice, R. R., and Drew, R. T. The effect ofexposure
regimen and duration on benzene-induced bone marrow damage
in mice. I. Sex comparisons in DBA/2 mice. Mutat. Res. 203:
251-271 (1988).
14. Luke, C. A., Tice, R. R., and Drew, R. T. The effect of exposure
regimen and duration on benzene-induced bone marrow damage
in mice. II. Strain comparisons involving B6C3F,, C57B1/6 and
DBA/2 male mice. Mutat. Res. 203: 273-295 (1988).
15. Tice, R. R., and Luke, C. L. The effect of exposure duration on
benzene-induced bone marrow damage in mice. Inhalation versus
oral gavage in male B6C3Fj mice. Submitted to Toxicol. Appl.
Pharmacol.
16. MacGregor, J. T., Wehr, C. M., andGould, D. H. Clastogen-induced
micronuclei in peripheral blood erythrocytes: The basis ofan im-
proved micronucleus test. Environ. Mutagen. 2: 509-514 (1980).
17. Schlegel, R., andMacGregor, J. T. The persistence ofmicronuclei
inperipheral blood erythrocytes: detection ofchronic chromosome
breakage in mice. Mutat. Res. 104: 367-369 (1982).
18. Irons, R. D. Metabolism ofbenzene and mechanisms ofits toxic-
ity. Collegium Ramazzini International Conference on Benzene,
November 3-4, New York, 1983.
19. Heddle, J. A., Hite, M., Kirkhart, B., Mavournin, K., MacGregor,
J. T., Newell, G. W., and Salamone, M. F. The induction of
micronuclei as a measure ofgenotoxicity. A report ofthe U.S. En-
vironmental Protection Agency Gene-Tox Program. Mutat. Res.
123: 61-118 (1983).
20. Snyder, C. A., Goldstein, B. D., Sellakumar, A., Wollman, S. R.,
Bromberg, I., Erlichman, M. N., and Laskin, S. Hematotoxicity
ofinhaledbenzene to Sprague-Dawley rats and AKR mice at 300
ppm. J. Toxicol. Environ. Health 4: 605-618 (1978).
21. Green, J. D., Snyder, C. A., LoBue, J., Goldstein, B. D., and Al-
bert, R. E. Acute and chronic dose/response effect ofbenzene in-
halation on the peripheral blood, bone marrow, and spleen cells of74 TICE, LUKE, AND DREW
CD-1 male mice. Toxicol. Appl. Pharmacol. 59: 204-214 (1981).
22. Snyder, C. A., Erlichman, M. N., Laskin, S., Goldstein, B. D., and
Albert, R. E. The pharmacokinetics of repetitive benzene ex-
posures at 300 and 100 ppm in AKR mice and Sprague-Dawley
rats. Toxicol. Appl. Pharmacol 57: 164-171 (1981).
23. Tice, R. R., Vogt, T. F., and Costa, D. L. Cytogenetic effects of
inhaled benzene in murine bone marrow. In: Genotoxic Effects of
Airborne Agents(R. R. Tice, D. L. Costa, and K. M. Schaich, Eds.),
Plenum Press, New York, 1982, pp. 257-275.
24. Cortina, T. A., Sica, E. W.,McCarroll, N. E., Coate,W.,Thakur, A.,
and Farrow, M. G. Inhalation cytogenetics in mice and rats ex-
posed to benzene. In: Advances in Modern Environmental Toxi-
cology, Vol. 6 (H. N. MacFarland, C. E. Holdsworth, J. A. Mac-
Gregor, R. W. Call, and M. L. Lane, Eds.), Princeton Scientific
Publishers, Princeton, NJ, 1984, pp. 81-88.
25. Wells, M., and Nerland, D. E. Nonlinear relationships between
benzene exposure and bloodlevels ofbenzene in mice. Fed. Proc.
43: 759 (1984).
26. Nebert, D. W. The Ah locus. Genetic differences in toxic and
tumorigenic response to foreign compounds. In: Microsomes, Drug
Oxidations, and Chemical Carcinogenesis. Academic Press, New
York, 1980, pp. 801-811.
27. Longacre, S. L., Kocsis, J. J., and Snyder, R. Influence ofstrain
differences in mice on the metabolism and toxicity ofbenzene. Tox-
icol. Appl. Pharamcol. 60: 398-409 (1981).
28. Harper, B. L., and Legator, M. Pyridine prevents the clastogenic-
ity of benzene but not of benzo(a)pyrene or cyclophosphamide.
Mutat. Res. 179: 23-31 (1987).
29. Dixon, W. J., Ed. BMPD Statistical Software. University Press,
Berkeley, CA, 1985.
30. Tice, R. R., and Ivett, J. L. Cytogenetic analysis ofbone marrow
damage. In: Toxicology of the Blood and Bone Marrow (R. D.
Irons, Ed.), Raven Press, New York, 1985, pp. 119-140.
31. Hayashi, M., Sofuni, T., and Ishidate, M., Jr. Kinetics of
micronucleus formation in relation to chromosomal aberrations in
mouse bone marrow. Mutat. Res. 127: 129-137 (1984).
32. Snyder, R., Uzuki, F., Gonasun, L., Bromfield, E., andWells, A.
The metabolism ofbenzene in vitro. Toxicol. Appl. Pharmacol. 11:
346-360 (1967).
33. Gonasun, L. M., Witmer, C. M., Kocsis, J. J., and Snyder, R. In
vivo metabolism in mouse liver microsomes. Toxicol. Appl. Phar-
macol. 26: 398-406 (1973).
34. Post, G. B., and Snyder, R. Effects of enzyme induction on
microsomal benzene induction. J. Toxicol. Environ. Health 11:
811-825 (1983).
35. Driscoll, K. E., and Snyder, C. A. The effects ofethanol injection
and repeated benzene exposures on benzene pharmacokinetics.
Toxicol. Appl. Pharmacol. 73: 525-535 (1984).
36. Pathiratne, A., Puyear, R. L., and Brammer, J. D. Acomparative
study of the effects ofbenzene, toluene, and xylenes on their in
vitro metabolism and drug-metabolizing enzymes in rat liver. Tox-
icol. Appl. Pharmacol. 82: 272-280 (1986).
37. Sabourin, P. J., Chen, T.-H., Lucier, G., Birnbaum, L. S., Fisher, E.,
and Henderson, R. F. Effect ofdose on the absorption and excre-
tion of"1C benzene administered orally orbyinhalation in rats and
mice. Toxicol. Appl. Pharmacol. 87: 325-336 (1987).
38. Henderson, R. F., Sabourin, P. J., Bechtold, W. E., Griffith, W. C.,
Medinsky, M. A., Birnbaum, L. S., and Lucier, G. The effect of
dose, dose rate, route ofadministration, and species on tissue and
bloodlevels ofbenzene metabolites. Environ. Health Perspect. 82:
9-17 (1989).